How is an induced sputum eosinophil count performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Perform Induced Sputum Eosinophil Count

The procedure involves patients inhaling increasing concentrations of hypertonic saline solution (3%, 4%, and 5%) sequentially for 5 minutes each via an ultrasonic nebulizer after premedication with a short-acting bronchodilator. 1

Pre-Procedure Preparation

  • Premedicate with a short-acting bronchodilator to prevent bronchospasm during the procedure 1
  • Ensure spirometry and baseline assessment are completed beforehand

Sputum Induction Protocol

The standardized induction sequence follows these steps:

  • Nebulize 3% hypertonic saline for 5 minutes
  • Nebulize 4% hypertonic saline for 5 minutes
  • Nebulize 5% hypertonic saline for 5 minutes
  • Use an ultrasonic nebulizer for all concentrations 1
  • Patient expectorates sputum after each inhalation period

Sample Processing

Critical timing requirement: Same-day processing is mandatory for cell quantification and viability 1. The processing steps are:

  1. Disperse expectorated sputum using a mucolytic agent (typically dithiothreitol/DTT)
  2. Filter through 48-μm mesh gauze to remove excess mucus 1
  3. Centrifuge the filtrate to produce a cytospin
  4. Prepare cytospin slides for differential cell counting

Cell Counting and Interpretation

  • Count 400 nonsquamous cells on the cytospin to obtain differential cell count 1
  • Eosinophilia threshold: ≥3% non-squamous cell eosinophil count indicates eosinophilic bronchitis, as this exceeds the 90th percentile for healthy patients (1.1%) 1
  • The 2009 ATS/ERS guidelines note that >1.9% is outside the normal range 2

Important Clinical Considerations

The test is safe, valid, and repeatable for measuring airway inflammation 1, but several caveats exist:

  • Requires specialized laboratory capability and trained technicians for same-day processing
  • Cannot be stored like routine cytology specimens
  • If sputum induction is unavailable or unsuccessful, bronchial wash fluid obtained at bronchoscopy provides similar information 1
  • The test can also identify neutrophilia from viral or bacterial bronchitis, which are alternative causes of chronic cough 1

Alternative Simplified Method

A newer SSIMPLE method using formalin-fixed, paraffin-embedded (FFPE) sputum plugs has shown excellent correlation with standard DTT processing (ρ=0.9), with ≥2.6% eosinophils as the cut-off (sensitivity 85.4%, specificity 93.0%) 3. This method eliminates the same-day processing requirement but requires validation in your specific clinical setting.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.